«
»

Top

A new invention to help surgeons during operations on cancer patients

Published 8 Sep 2017 • Updated 23 May 2019 • By Josephine O'Brien

A new invention to help surgeons during operations on cancer patients

A pen-sized device could soon help cancer surgeons tell whether the tissue they plan to cut out of a person is cancerous or healthy.

It usually takes several days for pathologists to analyse a tissue sample to decide if it’s cancerous. But the new device, which gives instant feedback, could be used by surgeons to make sure they cut out the whole tumour, preventing relapses caused by missed tissue.

The device has a disposable nozzle on its tip. When placed on suspected tissue, a tiny drop of water on the nozzle soaks up biological material – such as fats, proteins and sugars – from the tissue surface.

These samples can then be transferred to a mass spectrometer, which compares the combination of biomolecules with a database of similar data. Algorithms can produce a conclusion on whether the tissue is likely to be safe or cancerous within 10 seconds.

“It gave the right answer 96 per cent of the time,” Livia Eberlin, of the University of Texas, whose team has tested their pen on 253 human tissue samples.

Preventing relapses

These samples included cancerous cells from lungs, ovaries, thyroids and breasts, as well as healthy tissue. The team have also used to pen to guide tumour removal surgeries in mice, and hope to test it in hospitals next year.

The speed and accuracy of our device could really help on treatment options and decisions,” says Eberlin. Around 10 per cent of relapses result from the re-growth of tissue missed during surgery, she says.

Once this pre-clinical data has been validated in clinical trials, the pen-size mass spectrometry might improve diagnosis during operations, and help identify micro-metastatic cancer deposits,” comments Nicola Valeri, a cancer surgeon at the Royal Marsden NHS Trust in London. He agrees that this could lead to more precise operations to remove various types of cancer.

New Scientist

avatar Josephine O'Brien

Author: Josephine O'Brien, Community Manager UK

Josephine is the Community Manager of the UK with a Master’s in Publishing. She is a strong believer in the power of words and strives to make Carenity UK a comforting, vibrant and informative community for both... >> Learn more

Comments

You will also like

World Cancer Day: Facts and Insights!

Adamantinoma
Adrenocortical carcinoma
Anaplastic large cell lymphoma
Bladder cancer
Brain tumour
Breast cancer
Cancer
Catecholamine-secreting tumour
Cervical cancer
Colorectal cancer
Cutaneous lymphoma
Cutaneous T-cell lymphoma
Diffuse large B-cell lymphoma
Endocrine cancer
Endocrine tumour
Endometrial cancer
Enteropancreatic endocrine tumour
Ewing sarcoma
Follicular lymphoma
Gallbladder cancer
Gastrointestinal stromal tumour
Glial tumour
Hodgkin lymphoma
Kaposi sarcoma
Larynx cancer
Leukemia
Liver cancer
Lung cancer
Malignant tumour of the fallopian tube
Mantle cell lymphoma
Merkel tumour
Mesothelioma
Multiple endocrine neoplasia
Multiple myeloma
Nephroblastoma
Neuroblastoma
Non-Hodgkin lymphoma
Ollier disease
Osteosarcoma
Pancreatic cancer
Pheochromocytoma
Primary peritoneal tumour
Prostate cancer
Pseudomyxoma peritonei
Rare bone tumour
Renal cancer
Rhabdoid tumour
Sézary syndrome
Skin cancer
Small cell lung cancer
Squamous cell carcinoma of head and neck
Systemic mastocytosis
Testicular cancer
Thyroid cancer
Tumours of the heart
Waldenström macroglobulinemia
xyz_Colon cancer

World Cancer Day: Facts and Insights!

Read the article
Telling patients to 'fight' cancer puts them under pressure

Adamantinoma
Adrenocortical carcinoma
Anaplastic large cell lymphoma
Bladder cancer
Brain tumour
Breast cancer
Cancer
Catecholamine-secreting tumour
Cervical cancer
Colorectal cancer
Cutaneous lymphoma
Cutaneous T-cell lymphoma
Diffuse large B-cell lymphoma
Endocrine cancer
Endocrine tumour
Endometrial cancer
Enteropancreatic endocrine tumour
Ewing sarcoma
Follicular lymphoma
Gallbladder cancer
Gastrointestinal stromal tumour
Glial tumour
Hodgkin lymphoma
Kaposi sarcoma
Larynx cancer
Leukemia
Liver cancer
Lung cancer
Malignant tumour of the fallopian tube
Mantle cell lymphoma
Merkel tumour
Mesothelioma
Multiple endocrine neoplasia
Multiple myeloma
Nephroblastoma
Neuroblastoma
Non-Hodgkin lymphoma
Ollier disease
Osteosarcoma
Pancreatic cancer
Pheochromocytoma
Primary peritoneal tumour
Prostate cancer
Pseudomyxoma peritonei
Rare bone tumour
Renal cancer
Rhabdoid tumour
Sézary syndrome
Skin cancer
Small cell lung cancer
Squamous cell carcinoma of head and neck
Systemic mastocytosis
Testicular cancer
Thyroid cancer
Tumours of the heart
Waldenström macroglobulinemia
xyz_Colon cancer

Telling patients to 'fight' cancer puts them under pressure

Read the article
Cancer death rate to be cut by 22,000 using artificial intelligence – PM

Cancer

Cancer death rate to be cut by 22,000 using artificial intelligence – PM

Read the article
Lung cancer destroyed with tea leaf nanoparticles

Bladder cancer
Brain tumour
Breast cancer
Cancer
Cervical cancer
Endocrine cancer
Endometrial cancer
Gallbladder cancer
Gastrointestinal stromal tumour
Larynx cancer
Liver cancer
Pancreatic cancer
Prostate cancer
Renal cancer
Testicular cancer
Thyroid cancer
xyz_Colon cancer

Lung cancer destroyed with tea leaf nanoparticles

Read the article

Most commented discussions

Fact sheets